← Leaderboards
Kenneth S Polonsky
Washington University
$50,574,664
Attributed
$50,824,663
Total exposure
45
Grants
30
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $19.8M · FY2005–13$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$74,159,581 · 46
By mechanism
UL1$55,106,497 · 19
KL2$4,818,399 · 1
R01$4,431,243 · 1
K12$3,427,681 · 1
R37$2,043,923 · 1
TL1$1,151,818 · 1
Top collaborators
- Burton M Wice1 shared
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchInsulinHuman SubjectDiabetes MellitusNoninsulin Dependent Diabetes MellitusPancreatic Islet FunctionUniversitiesFundingHealth Science ResearchWashingtonClinical TrialsTranslational ResearchInstitutesGrantGlucose ToleranceBaseGlucoseInsulin Sensitivity /ResistanceDiabetes EducationProgramsResourcesResearch PersonnelSecretionInstitution
Grant awards (112)
REGULATION OF HEPATIC INSULIN EXTRACTION$474,792
R01 · FY2013 · DK · contact PI
REGULATION OF HEPATIC INSULIN EXTRACTION$485,760
R01 · FY2012 · DK · contact PI
REGULATION OF HEPATIC INSULIN EXTRACTION$479,073
R01 · FY2011 · DK · contact PI
WASHINGTON UNIVERSITY INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCES$4,218,331
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$1,856,065
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$1,687,332
UL1 · FY2010 · RR · contact PI
REGULATION OF HEPATIC INSULIN EXTRACTION$581,947
R01 · FY2010 · DK · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$337,467
UL1 · FY2010 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$337,466
UL1 · FY2010 · RR · contact PI
REGULATION OF HEPATIC INSULIN EXTRACTION$15,837
R01 · FY2010 · DK · contact PI
Washington University Institute of Clinical and Translational Sciences (UL1)$8,338,248
UL1 · FY2009 · RR · contact PI
WASHINGTON UNIVERSITY INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCES$5,102,507
UL1 · FY2009 · RR · contact PI
Washington University Institute of Clinical and Translational Sciences (KL2)$1,728,410
KL2 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$1,376,895
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$1,376,895
UL1 · FY2009 · RR · contact PI
A PROOF-OF-CONCEPT CLINICAL TRIAL OF XENIN-25 IN THE TREATMENT OF TYPE 2 DIABETES$499,999
RC1 · FY2009 · DK · contact PI
Regulation of Hepatic Insulin Extraction$490,857
R01 · FY2009 · DK · contact PI
Washington University Institute of Clinical and Translational Sciences (TL1)$446,906
TL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$240,976
UL1 · FY2009 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$240,975
UL1 · FY2009 · RR · contact PI
Washington University Institute of Clinical and Translational Sciences (UL1)$8,177,780
UL1 · FY2008 · RR · contact PI
WASHINGTON UNIVERSITY INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCES$5,621,569
UL1 · FY2008 · RR · contact PI
Washington University Institute of Clinical and Translational Sciences (KL2)$1,683,627
KL2 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS$1,629,423
UL1 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH$733,220
UL1 · FY2008 · RR · contact PI
Regulation of Hepatic Insulin Extraction$476,466
R01 · FY2008 · DK · contact PI
Washington University Institute of Clinical and Translational Sciences (TL1)$356,236
TL1 · FY2008 · RR · contact PI
CTSA INFRASTRUCTURE FOR AIDS RESEARCH$193,568
UL1 · FY2008 · RR · contact PI
Washington University Institute of Clinical and Translational Sciences (UL1)$6,818,890
UL1 · FY2007 · RR · contact PI
WASHINGTON UNIVERSITY INSTITUTE CTSA FOR CLINICAL TRIALS$2,727,556
UL1 · FY2007 · RR · contact PI
WASHINGTON UNIVERSITY INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCES$2,727,556
UL1 · FY2007 · RR · contact PI
Washington University Institute of Clinical and Translational Sciences$1,406,362
KL2 · FY2007 · RR · contact PI
WASHINGTON UNIVERSITY INSTITUTE CTSA FOR PEDIATRIC RESEARCH$681,889
UL1 · FY2007 · RR · contact PI
WASHINGTON UNIVERSITY INSTITUTE CTSA FOR AIDS RESEARCH$681,889
UL1 · FY2007 · RR · contact PI
Regulation of Hepatic Insulin Extraction$472,036
R01 · FY2007 · DK · contact PI
Washington University Institute of Clinical and Translational Sciences (TL1)$348,676
TL1 · FY2007 · RR · contact PI
REGULATION OF HEPATIC INSULIN EXTRACTION$9,352
M01 · FY2007 · RR · contact PI
ISLET TRANSPLANTATION IN TYPE 1 DIABETIC PATIENTS USING THE EDMONTON PROTOCOL$1,084
M01 · FY2007 · RR · contact PI
ISLET FUNCTION & CLINICAL ANALYSES OF TRANSPLANT RECIPIENTS$406
M01 · FY2007 · RR · contact PI
Regulation of Hepatic Insulin Extraction$471,972
R01 · FY2006 · DK · contact PI
Interdisciplinary Research Careers in Women's Health$466,668
K12 · FY2006 · HD · contact PI
REGULATION OF HEPATIC INSULIN EXTRACTION$50,394
M01 · FY2006 · RR · contact PI
ISLET TRANSPLANTATION IN TYPE 1 DIABETIC PATIENTS USING THE EDMONTON PROTOCOL$3,332
M01 · FY2006 · RR · contact PI
ISLET FUNCTION & CLINICAL ANALYSES OF TRANSPLANT RECIPIENTS$833
M01 · FY2006 · RR · contact PI
A CLINICAL TRIAL OF GINSENG FOR GLUCOSE TOLERANCE$416
M01 · FY2006 · RR · contact PI
Interdisciplinary Research Careers in Women's Health$500,000
K12 · FY2005 · HD
Regulation of Hepatic Insulin Extraction$482,503
R01 · FY2005 · DK
A Clinical Trial of Ginseng for Glucose Intolerance$291,266
R21 · FY2005 · AT
REGULATION OF HEPATIC INSULIN EXTRACTION$94,066
M01 · FY2005 · RR
Regulation of Hepatic Insulin Extraction$61,200
R37 · FY2005 · DK
A CLINICAL TRIAL OF GINSENG FOR GLUCOSE TOLERANCE$32,862
M01 · FY2005 · RR
ISLET TRANSPLANTATION IN TYPE 1 DIABETIC PATIENTS USING THE EDMONTON PROTOCOL$9,037
M01 · FY2005 · RR
REGULATION OF HEPATIC INSULIN EXTRACTION$6,475
P41 · FY2005 · RR
ISLET FUNCTION &CLINICAL ANALYSES OF TRANSPLANT RECIPIENTS$3,287
M01 · FY2005 · RR
INTERDISCIPLINARY RESEARCH CAREERS IN WOMEN'S HEALTH$500,000
K12 · FY2004 · HD
Regulation of Hepatic Insulin Extraction$440,642
R37 · FY2004 · DK
A Clinical Trial of Ginseng for Glucose Intolerance$293,916
R21 · FY2004 · AT
Regulation of Hepatic Insulin Extraction$164,156
M01 · FY2004 · RR
Islet Transplantation in Type 1 Diabetic Patients using the Edmonton Protocol$44,712
M01 · FY2004 · RR
REGULATION OF HEPATIC INSULIN EXTRACTION$8,128
P41 · FY2004 · RR
Islet Function &Clinical Analyses of Transplant Recipients$4,791
M01 · FY2004 · RR
INTERDISCIPLINARY RESEARCH CAREERS IN WOMEN'S HEALTH$461,013
K12 · FY2003 · HD
Regulation of Hepatic Insulin Extraction$431,102
R37 · FY2003 · DK
INTERDISCIPLINARY RESEARCH CAREERS IN WOMEN'S HEALTH$500,000
K12 · FY2002 · HD
Regulation of Hepatic Insulin Extraction$473,221
R37 · FY2002 · DK
PATHOBIOLOGY OF BETA CELL DYSFUNCTION AND APOPTOSIS IN DIABETES MELLITUS$146,667
P01 · FY2002 · DK
PROINSULIN &CONVERSION PRODUCTS TO INSULINLIKE IMMUNOREACTIVITY IN IGT AND NIDDM$0
M01 · FY2002 · RR
TROGLITAZONE IN EARLY TYPE 2 DIABETES MELLITUS$0
M01 · FY2002 · RR
PLASMA LEPTIN LEVELS INDICATE ENERGY BALANCE$0
M01 · FY2002 · RR
EFFECT OF ELEVATED FFA ON INSULIN SECRETION$0
M01 · FY2002 · RR
BETA CELL FUNCTION IN SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE$0
M01 · FY2002 · RR
INSULIN SECRETION IN PANCREAS TRANSPLANT RECIPIENTS$0
M01 · FY2002 · RR
CORE--RADIOIMMUNOASSAY AND CLINICAL STUDIES LABORATORY$0
P60 · FY2002 · DK
CORE--RADIOIMMUNOASSAY AND CLINICAL STUDIES LABORATORY$0
P60 · FY2002 · DK
CORE--RADIOIMMUNOASSAY AND CLINICAL STUDIES LABORATORY$0
P60 · FY2002 · DK
PILOT AND FEASIBILITY STUDIES$0
P60 · FY2002 · DK
PILOT AND FEASIBILITY STUDIES$0
P60 · FY2002 · DK
PILOT AND FEASIBILITY STUDIES$0
P60 · FY2002 · DK
IS THE PANCREATIC BETA CELL TARGET OF INSULIN ACTION IN VIVO$0
M01 · FY2002 · RR
ALTERED INSULIN SECRETION IN PTS W GENETIC FORMS OF NID$0
M01 · FY2002 · RR
INTERDISCIPLINARY RESEARCH CAREERS IN WOMEN'S HEALTH$500,000
K12 · FY2001 · HD
REGULATION OF HEPATIC INSULIN EXTRACTION$323,455
R37 · FY2001 · DK
CORE--RADIOIMMUNOASSAY AND CLINICAL STUDIES LABORATORY$211,312
P60 · FY2001 · DK
PILOT AND FEASIBILITY STUDIES$211,312
P60 · FY2001 · DK
PATHOBIOLOGY OF BETA CELL DYSFUNCTION AND APOPTOSIS IN DIABETES MELLITUS$146,667
P01 · FY2001 · DK
CORE--RADIOIMMUNOASSAY AND CLINICAL STUDIES LABORATORY$0
P60 · FY2001 · DK
CORE--RADIOIMMUNOASSAY AND CLINICAL STUDIES LABORATORY$0
P60 · FY2001 · DK
PILOT AND FEASIBILITY STUDIES$0
P60 · FY2001 · DK
PILOT AND FEASIBILITY STUDIES$0
P60 · FY2001 · DK
INTERDISCIPLINARY RESEARCH CAREERS IN WOMEN'S HEALTH$500,000
K12 · FY2000 · HD
REGULATION OF HEPATIC INSULIN EXTRACTION$279,367
R37 · FY2000 · DK
CORE--RADIOIMMUNOASSAY AND CLINICAL STUDIES LABORATORY$261,639
P60 · FY2000 · DK
PILOT AND FEASIBILITY STUDIES$261,639
P60 · FY2000 · DK
PATHOBIOLOGY OF BETA CELL DYSFUNCTION AND APOPTOSIS IN DIABETES MELLITUS$219,493
P01 · FY2000 · DK
CORE--RADIOIMMUNOASSAY LABORATORY$170,000
P30 · FY2000 · DK
REGULATION OF HEPATIC INSULIN EXTRACTION$34,936
R37 · FY2000 · DK
TROGLITAZONE IN EARLY TYPE 2 DIABETES MELLITUS$32,779
M01 · FY2000 · RR
BETA CELL FUNCTION IN SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE$0
M01 · FY2000 · RR
BETA CELL FUNCTION IN SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE$0
M01 · FY2000 · RR
IS THE PANCREATIC BETA CELL TARGET OF INSULIN ACTION IN VIVO$0
M01 · FY2000 · RR
INSULIN SECRETION IN PANCREAS TRANSPLANT RECIPIENTS$0
M01 · FY2000 · RR
IS THE PANCREATIC BETA CELL TARGET OF INSULIN ACTION IN VIVO$0
M01 · FY2000 · RR
INSULIN SECRETION IN PANCREAS TRANSPLANT RECIPIENTS$0
M01 · FY2000 · RR
ALTERED INSULIN SECRETION IN PTS W GENETIC FORMS OF NID$0
M01 · FY2000 · RR
ALTERED INSULIN SECRETION IN PTS W GENETIC FORMS OF NID$0
M01 · FY2000 · RR
PROINSULIN &CONVERSION PRODUCTS TO INSULINLIKE IMMUNOREACTIVITY IN IGT AND NIDDM$0
M01 · FY2000 · RR
PROINSULIN &CONVERSION PRODUCTS TO INSULINLIKE IMMUNOREACTIVITY IN IGT AND NIDDM$0
M01 · FY2000 · RR
TROGLITAZONE IN EARLY TYPE 2 DIABETES MELLITUS$0
M01 · FY2000 · RR
PLASMA LEPTIN LEVELS INDICATE ENERGY BALANCE$0
M01 · FY2000 · RR
PLASMA LEPTIN LEVELS INDICATE ENERGY BALANCE$0
M01 · FY2000 · RR
EFFECT OF ELEVATED FFA ON INSULIN SECRETION$0
M01 · FY2000 · RR
EFFECT OF ELEVATED FFA ON INSULIN SECRETION$0
M01 · FY2000 · RR